Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. (2021)

First Author: PRINCIPLE Trial Collaborative Group
Attributed to:  Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00461-x

PubMed Identifier: 33676597

Publication URI: http://europepmc.org/abstract/MED/33676597

Type: Journal Article/Review

Volume: 397

Parent Publication: Lancet (London, England)

Issue: 10279

ISSN: 0140-6736